Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Solara Active Pharma Sciences Limited (NSE: SOLARA), ISIN INE624Z01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SOLARA last traded at ₹645.85 (+1.92%), with a 52-week range of ₹422.00 to ₹774.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 41.93%, FIIs 10.71%, DIIs 3.89%, mutual funds 0.87%.
EquiSense Score (ECS): 59/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.